Status:
COMPLETED
The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
Lead Sponsor:
Siriraj Hospital
Conditions:
Recalcitrant Alopecia Totalis
Recalcitrant Alopecia Universalis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The main purpose of this study is to determine the efficacy of intralesional botulinum toxin type A injection for recalcitrant alopecia totalis and alopecia universalis. Treatments of recalcitrant al...
Eligibility Criteria
Inclusion
- All patients must be over 18 years old
- All patients are diagnosed with alopecia totalis or alopecia universalis
- The alopecia condition was not responded to any treatments
Exclusion
- Having an active inflammation on scalp area
- Allergic to botulinum toxin A of human albumin
- Has been diagnosed with neuromuscular disorders
- Taking any medication that may interfere with botulinum toxin A action
- Receiving any treatment for alopecia condition within 4 weeks
- Pregnant , breastfeeding, plan to pregnant patients
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00997815
Start Date
December 1 2009
End Date
June 1 2011
Last Update
August 2 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok, Thailand, 10700